{"pre_text": ["equity compensation plan information the following table presents the equity securities available for issuance under our equity compensation plans as of december 31 , 2012 .", "equity compensation plan information plan category number of securities to be issued upon exercise of outstanding options , warrants and rights ( 1 ) weighted-average exercise price of outstanding options , warrants and rights ( 2 ) number of securities remaining available for future issuance under equity compensation plans ( excluding securities reflected in column ( a ) ) ( a ) ( b ) ( c ) equity compensation plans approved by security holders 3946111 $ 34.67 3608527 equity compensation plans not approved by security holders ( 3 ) 2014 2014 2014 ."], "post_text": ["( 1 ) includes grants made under the huntington ingalls industries , inc .", "2012 long-term incentive stock plan ( the \"2012 plan\" ) , which was approved by our stockholders on may 2 , 2012 , and the huntington ingalls industries , inc .", "2011 long-term incentive stock plan ( the \"2011 plan\" ) , which was approved by the sole stockholder of hii prior to its spin-off from northrop grumman corporation .", "of these shares , 1166492 were subject to stock options , 2060138 were subject to outstanding restricted performance stock rights , 641556 were restricted stock rights , and 63033 were stock rights granted under the 2011 plan .", "in addition , this number includes 9129 stock rights and 5763 restricted performance stock rights granted under the 2012 plan , assuming target performance achievement .", "( 2 ) this is the weighted average exercise price of the 1166492 outstanding stock options only .", "( 3 ) there are no awards made under plans not approved by security holders .", "item 13 .", "certain relationships and related transactions , and director independence information as to certain relationships and related transactions and director independence will be incorporated herein by reference to the proxy statement for our 2013 annual meeting of stockholders to be filed within 120 days after the end of the company 2019s fiscal year .", "item 14 .", "principal accountant fees and services information as to principal accountant fees and services will be incorporated herein by reference to the proxy statement for our 2013 annual meeting of stockholders to be filed within 120 days after the end of the company 2019s fiscal year. ."], "table": [["plan category", "number of securities to be issued upon exercise of outstanding options warrants and rights ( 1 ) ( a ) ( b )", "weighted-average exercise price of outstanding optionswarrants and rights ( 2 )", "number of securities remaining available for future issuance under equity compensation plans ( excluding securitiesreflected in column ( a ) ) ( c )"], ["equity compensation plans approved by security holders", "3946111", "$ 34.67", "3608527"], ["equity compensation plans not approved by security holders ( 3 )", "2014", "2014", "2014"], ["total", "3946111", "$ 34.67", "3608527"]], "table_ori": [["Plan category", "Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights<sup>(1)</sup> (a)(b)", "Weighted-Average Exercise Price of Outstanding Options,Warrants and Rights<sup>(2)</sup>", "Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding SecuritiesReflected in Column (a)) (c)"], ["Equity compensation plans approved by security holders", "3,946,111", "$34.67", "3,608,527"], ["Equity compensation plans not approved by security holders<sup>(3)</sup>", "—", "—", "—"], ["Total", "3,946,111", "$34.67", "3,608,527"]]}

Question: what is the ratio of the number of securities to be issued to the number of securities remaining available
Evidence:
table_3: plan category the total of number of securities to be issued upon exercise of outstanding options warrants and rights ( 1 ) ( a ) ( b ) is 3946111 ; the total of weighted-average exercise price of outstanding optionswarrants and rights ( 2 ) is $ 34.67 ; the total of number of securities remaining available for future issuance under equity compensation plans ( excluding securitiesreflected in column ( a ) ) ( c ) is 3608527 ;
Program: divide(3946111, 3608527)
Answer:
str_answer: 1.1
exe_answer: 1.09355